Innovative Medical Devices for Neurosurgery

Renishaw is introducing a range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) taking place in Toronto, Canada, from May 24 - 27, 2009. These include the neuromate surgical robot, and image-guided stereotactic technologies, some of which are still in development.

To mark the formal introduction of Renishaw’s neurosurgical portfolio at WSSFN, the company will also be hosting a special satellite event at the Toronto Cricket Club on Sunday May 24. Two leading neurosurgeons will give lectures about their experiences with surgical robotics and other new stereotactic technologies, and their vision for their future use.

Dr Olivier Delalande, Pediatric Neurosurgeon at the Fondation Rothschild Hospital in Paris, France, will discuss his pioneering use of the neuromate stereotactic robot to perform pediatric procedures including Stereo Electro-Encephalography (SEEG) for epilepsy, and neuroendoscopic disconnection for hypothalamic hamartoma.

From Frenchay Hospital in Bristol, England, Professor Steven Gill, who is well known for his pioneering work in placing Deep Brain Stimulation (DBS) leads, will also discuss the clinical applications of new technologies in the targeted delivery of therapeutics and their drive towards the requirement for advanced stereotactic systems.

Speaking about his company’s first appearance at WSSFN, Sir David McMurtry, Renishaw’s Chairman and Chief Executive, said, “Our commitment to the neurosurgical market is built around listening to the needs of our clinical customers and then delivering advanced precision systems to meet their requirements. We are passionate about our products and ever mindful of the impact that they can have on patients’ lives.”

www.renishaw.com